Life Sciences & Medicine Active Updated Nov 16, 2026

Stem cells with a bone-marrow address for osteoporosis

Where it stands as of Nov 16, 2026

A first-in-human trial in Cell gave ten women over 50 with advanced osteoporosis a single infusion of their own stem cells coated in a sugar that steers them to bone marrow. Fractures across the group fell from an average of eight per year to 0.5 per year over two years. Ten patients is a very small group, there was no control arm described, and where the cells went after infusion was not tracked.

The story so far

  1. Nov 16, 2026 Latest

    A first-in-human trial in Cell gave ten women over 50 with advanced osteoporosis one infusion of their own mesenchymal stem cells coated in a sugar that acts as a return address for bone marrow. Fractures fell from an average of eight per year to 0.5 per year over two years, bone-tissue area rose about 70 percent at four months, and patients reported 34 percent less bone pain. Co-author Robert Sackstein holds intellectual-property rights to the cell-engineering technology.

    Today Got Better

This story moves with the morning letter.

When this question gets a new answer, the page above changes the same morning. Each morning's letter brings the day's progress in science, medicine and beyond. Free, every day.